CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Beginning balances at Dec. 31, 2023	$ 124,701		$ 278,881	$ 275	$ (154,455)
Beginning balances, shares at Dec. 31, 2023		29,741,445
Issuance of common stock under the ESPP	124		124
Issuance of common stock under the ESPP, Shares		45,288
Issuance of common stock upon exercise of stock options	225		225
Issuance of common stock upon exercise of stock options shares		28,930
Vesting of early exercised stock options	1		1
Stock-based compensation	2,385		2,385
Unrealized gain (loss) on available-for-sale investments	(222)			(222)
Net loss	(16,617)				(16,617)
Ending balances at Mar. 31, 2024	110,597		281,616	53	(171,072)
Ending balances, shares at Mar. 31, 2024		29,815,663
Beginning balances at Dec. 31, 2023	124,701		278,881	275	(154,455)
Beginning balances, shares at Dec. 31, 2023		29,741,445
Net loss	(31,100)
Ending balances at Jun. 30, 2024	98,354		283,888	(27)	(185,507)
Ending balances, shares at Jun. 30, 2024		29,829,040
Beginning balances at Mar. 31, 2024	110,597		281,616	53	(171,072)
Beginning balances, shares at Mar. 31, 2024		29,815,663
Vesting of early exercised stock options	1		1
Issuance of common stock upon release of restricted stock units, shares		13,377
Stock-based compensation	2,271		2,271
Unrealized gain (loss) on available-for-sale investments	(80)			(80)
Net loss	(14,435)				(14,435)
Ending balances at Jun. 30, 2024	98,354		283,888	(27)	(185,507)
Ending balances, shares at Jun. 30, 2024		29,829,040
Beginning balances at Dec. 31, 2024	81,849		287,594	31	(205,776)
Beginning balances, shares at Dec. 31, 2024		29,919,634
Issuance of common stock under the ESPP	38		38
Issuance of common stock under the ESPP, Shares		42,797
Issuance of common stock upon exercise of stock options	27		27
Issuance of common stock upon exercise of stock options shares		63,124
Issuance of common stock upon release of restricted stock units, shares		115,962
Stock-based compensation	2,047		2,047
Unrealized gain (loss) on available-for-sale investments	17			17
Net loss	(10,649)				(10,649)
Ending balances at Mar. 31, 2025	73,329		289,706	48	(216,425)
Ending balances, shares at Mar. 31, 2025		30,141,517
Beginning balances at Dec. 31, 2024	$ 81,849		287,594	31	(205,776)
Beginning balances, shares at Dec. 31, 2024		29,919,634
Issuance of common stock upon exercise of stock options shares	63,124
Net loss	$ (17,100)
Ending balances at Jun. 30, 2025	68,842		291,704	25	(222,887)
Ending balances, shares at Jun. 30, 2025		27,376,461
Beginning balances at Mar. 31, 2025	73,329		289,706	48	(216,425)
Beginning balances, shares at Mar. 31, 2025		30,141,517
Issuance of common stock upon release of restricted stock units, shares		34,944
Stock-based compensation	1,998		1,998
Unrealized gain (loss) on available-for-sale investments	(23)			(23)
Issuance of pre-funded warrants in exchange for common stock, shares		(2,800,000)
Net loss	(6,462)				(6,462)
Ending balances at Jun. 30, 2025	$ 68,842		$ 291,704	$ 25	$ (222,887)
Ending balances, shares at Jun. 30, 2025		27,376,461